Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Activity of ofloxacin and pefloxacin against Mycobacterium leprae in mice.

Literature DB >> 3475035

Activity of ofloxacin and pefloxacin against Mycobacterium leprae in mice.

S R Pattyn.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 1987 PMID： 3475035 PMCID： PMC174807 DOI： 10.1128/AAC.31.4.671

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

12 in total

1. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.

Authors: J S Wolfson; D C Hooper
Journal: Antimicrob Agents Chemother Date: 1985-10 Impact factor: 5.191

2. Rapid bactericidal effect of rifampin on Mycobacterium leprae.

Authors: C C Shepard; L Levy; P Fasal
Journal: Am J Trop Med Hyg Date: 1972-07 Impact factor: 2.345

3. Statistical analysis of results obtained by two methods for testing drug activity against Mycobacterium leprae.

Authors: C C Shepard
Journal: Int J Lepr Other Mycobact Dis Date: 1982-03

4. In vitro antimycobacterial activity of a new antibacterial substance DL-8280--differentiation between some species of mycobacteria and related organisms by the DL-8280 susceptibility test.

Authors: M Tsukamura
Journal: Microbiol Immunol Date: 1983 Impact factor: 1.955

5. In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.

Authors: J D Gay; D R DeYoung; G D Roberts
Journal: Antimicrob Agents Chemother Date: 1984-07 Impact factor: 5.191

6. In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives.

Authors: D L Van Caekenberghe; S R Pattyn
Journal: Antimicrob Agents Chemother Date: 1984-04 Impact factor: 5.191

7. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.

Authors: H L Muytjens; J van der Ros-van de Repe; G van Veldhuizen
Journal: Antimicrob Agents Chemother Date: 1983-08 Impact factor: 5.191

8. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

Authors: R Wise; J M Andrews; L J Edwards
Journal: Antimicrob Agents Chemother Date: 1983-04 Impact factor: 5.191

9. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.

Authors: C M Bassey; A L Baltch; R P Smith
Journal: J Antimicrob Chemother Date: 1986-05 Impact factor: 5.790

10. The comparative in-vitro activity of pefloxacin.

Authors: A King; I Phillips
Journal: J Antimicrob Chemother Date: 1986-04 Impact factor: 5.790

8 in total

1. Another view of the therapy of leprosy.

Authors: R H Gelber
Journal: Antimicrob Agents Chemother Date: 1998-12 Impact factor: 5.191

Review 2. Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors: J H Paton; D S Reeves
Journal: Drugs Date: 1988-08 Impact factor: 9.546

Review 3. Leprosy.

Authors: R C Hastings; T P Gillis; J L Krahenbuhl; S G Franzblau
Journal: Clin Microbiol Rev Date: 1988-07 Impact factor: 26.132

Review 8. Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients.

Authors: Rossilene Conceição da Silva Cruz; Samira Bührer-Sékula; Maria Lúcia F Penna; Gerson Oliveira Penna; Sinésio Talhari
Journal: An Bras Dermatol Date: 2017 Nov-Dec Impact factor: 1.896